West Asia Organization for Cancer Prevention (WAOCP), APOCP's West Asia Chapter. Asian Pacific Journal of Cancer Prevention 1513-7368 23 4 2022 04 01 Use and Applicability of the Gail Model to Calculate Breast Cancer Risk: A Scoping Review 1117 1123 90085 10.31557/APJCP.2022.23.4.1117 EN Kely Paviani Stevanato Health Sciences Center, State University of Maringá, Paraná, Brazil. 0000-0003-1872-8246 Raíssa Bocchi Pedroso Health Sciences Center, State University of Maringá, Paraná, Brazil. 0000-0002-0076-1032 Catia Millene Dell Agnolo Health Sciences Center, State University of Maringá, Paraná, Brazil. 0000-0002-7312-6451 Lander Dos Santos Health Sciences Center, State University of Maringá, Paraná, Brazil. 0000-0001-7734-2189 Fernando Castilho Pelloso Department of Medicine, Federal University of Paraná, Curitiba, Paraná, Brazil. 0000-0001-6233-3968 Maria Dalva De Barros Carvalho Health Sciences Center, State University of Maringá, Paraná, Brazil. 0000-0002-1377-3331 Sandra Marisa Pelloso Health Sciences Center, State University of Maringá, Paraná, Brazil. 0000-0001-8455-6839 Journal Article 2021 02 24 Objective: To perform a scoping review of the applicability of the Gail model in different countries for different ethnicities. Methods: The review was conducted based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) checklist and search strategies based on the PICOS approach. The reviewed articles were included if they were published between 2013 and 2018 in English, Portuguese, or Spanish; were original articles available in full online; and described the use of the Gail model. The PubMed, Embase, and Web of Science data bases were searched. Results: A total of 38 articles eligible for analysis were identified, of which 16 used the Gail model to assess breast cancer risk in women, eight analyzed the applicability of this tool in their population, seven compared the tool and/or modified it according to the specific risk factors of their population, and seven cited the model in determining eligibility for chemoprevention. Conclusion: The Gail model has different applicabilities Greater effectiveness and breast cancer risk are found in developed countries. https://journal.waocp.org/article_90085_34c6bcdb0a13de01f708e69f76ac2cd3.pdf